Astrana Health (NASDAQ:ASTH) Shares Gap Up on Analyst Upgrade

Astrana Health, Inc. (NASDAQ:ASTH) gapped up prior to trading on Wednesday after Robert W. Baird raised their price target on the stock from $67.00 to $86.00. The stock had previously closed at $42.91, but opened at $44.86. Robert W. Baird currently has an outperform rating on the stock. Astrana Health shares last traded at $44.39, with a volume of 50,865 shares changing hands.

A number of other equities research analysts have also recently issued reports on the company. Truist Financial upped their price objective on Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. TD Cowen began coverage on shares of Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 price target for the company. BTIG Research boosted their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. KeyCorp assumed coverage on shares of Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Stifel Nicolaus lifted their price target on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $65.17.

Institutional Investors Weigh In On Astrana Health

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. GAMMA Investing LLC acquired a new stake in shares of Astrana Health during the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC bought a new position in Astrana Health in the third quarter valued at about $35,000. KBC Group NV acquired a new stake in shares of Astrana Health during the third quarter valued at about $70,000. Quest Partners LLC bought a new stake in shares of Astrana Health during the third quarter worth about $133,000. Finally, Central Pacific Bank Trust Division acquired a new position in shares of Astrana Health in the third quarter valued at approximately $160,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Trading Down 0.0 %

The business’s fifty day moving average is $55.30 and its 200-day moving average is $47.68. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.84 and a current ratio of 1.91. The firm has a market cap of $2.06 billion, a P/E ratio of 32.23, a price-to-earnings-growth ratio of 2.01 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same quarter in the previous year, the business earned $0.47 earnings per share. Analysts predict that Astrana Health, Inc. will post 1.16 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.